Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has entered into a definitive agreement […]
Provepharm Life Solutions Obtains FDA Authorization to Produce its Active Ingredients for the United States
Provepharm Life Solutions, a French private pharmaceutical company that finds new applications for well-known molecules, […]
Novarad Partners with CureMetrix to Advance AI-Driven Mammography
Novarad, a leader in the development of medical imaging software, today announced a partnership with […]
Therapixel Receives FDA Clearance for Use of its AI-based Breast Cancer Screening Software MammoScreen® on Digital Breast Tomosynthesis
Therapixel, a company leading the use of AI-based products for women’s health, announces it has […]
Quell Therapeutics Raises $156 Million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform
Quell Therapeutics Ltd (“Quell”), the world leader in the development of engineered T-regulatory (Treg) cell […]
Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Total NHS Covid Vaccines Top 96 Million, Amid Concern Over New Variant
Total Covid vaccinations in England have hit the 96 million mark as the NHS Covid-19 […]
Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and […]
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY ® in Children 5 to under 12 Years of Age in the European Union
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for […]
Targeted Drug Recommended to Treat Some Advanced Lung Cancer Patients
The National Institute for Health and Care Excellence (NICE) has recommended the use of selpercatinib (Retevmo) for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more